214 related articles for article (PubMed ID: 29883088)
1. Size-Controlled Iron Oxide Nanoplatforms with Lipidoid-Stabilized Shells for Efficient Magnetic Resonance Imaging-Trackable Lymph Node Targeting and High-Capacity Biomolecule Display.
Clauson RM; Chen M; Scheetz LM; Berg B; Chertok B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20281-20295. PubMed ID: 29883088
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.
Madru R; Kjellman P; Olsson F; Wingårdh K; Ingvar C; Ståhlberg F; Olsrud J; Lätt J; Fredriksson S; Knutsson L; Strand SE
J Nucl Med; 2012 Mar; 53(3):459-63. PubMed ID: 22323777
[TBL] [Abstract][Full Text] [Related]
3. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T
Shen Z; Chen T; Ma X; Ren W; Zhou Z; Zhu G; Zhang A; Liu Y; Song J; Li Z; Ruan H; Fan W; Lin L; Munasinghe J; Chen X; Wu A
ACS Nano; 2017 Nov; 11(11):10992-11004. PubMed ID: 29039917
[TBL] [Abstract][Full Text] [Related]
5. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Ling D; Lee N; Hyeon T
Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
[TBL] [Abstract][Full Text] [Related]
9. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo.
Vu-Quang H; Yoo MK; Jeong HJ; Lee HJ; Muthiah M; Rhee JH; Lee JH; Cho CS; Jeong YY; Park IK
Acta Biomater; 2011 Nov; 7(11):3935-45. PubMed ID: 21763797
[TBL] [Abstract][Full Text] [Related]
11. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
12. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.
Truzzi E; Bongio C; Sacchetti F; Maretti E; Montanari M; Iannuccelli V; Vismara E; Leo E
Molecules; 2017 Jun; 22(6):. PubMed ID: 28598368
[TBL] [Abstract][Full Text] [Related]
14. MR contrast in mouse lymph nodes with subcutaneous administration of iron oxide particles: size dependency.
Mori Y; Umeda M; Fukunaga M; Ogasawara K; Yoshioka Y
Magn Reson Med Sci; 2011; 10(4):219-27. PubMed ID: 22214906
[TBL] [Abstract][Full Text] [Related]
15. Mannose-poly(ethylene glycol)-linked SPION targeted to antigen presenting cells for magnetic resonance imaging on lymph node.
Muthiah M; Vu-Quang H; Kim YK; Rhee JH; Kang SH; Jun SY; Choi YJ; Jeong YY; Cho CS; Park IK
Carbohydr Polym; 2013 Feb; 92(2):1586-95. PubMed ID: 23399193
[TBL] [Abstract][Full Text] [Related]
16. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
Bonvin D; Bastiaansen JAM; Stuber M; Hofmann H; Mionić Ebersold M
Dalton Trans; 2017 Sep; 46(37):12692-12704. PubMed ID: 28914298
[TBL] [Abstract][Full Text] [Related]
17. Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystems.
Tombácz E; Turcu R; Socoliuc V; Vékás L
Biochem Biophys Res Commun; 2015 Dec; 468(3):442-53. PubMed ID: 26275707
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
[TBL] [Abstract][Full Text] [Related]
19. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
Vangijzegem T; Stanicki D; Laurent S
Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.
Cotin G; Blanco-Andujar C; Perton F; Asín L; de la Fuente JM; Reichardt W; Schaffner D; Ngyen DV; Mertz D; Kiefer C; Meyer F; Spassov S; Ersen O; Chatzidakis M; Botton GA; Hénoumont C; Laurent S; Greneche JM; Teran FJ; Ortega D; Felder-Flesch D; Begin-Colin S
Nanoscale; 2021 Sep; 13(34):14552-14571. PubMed ID: 34473175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
